Influential doctors aren’t disclosing their drug company ties

After reports in the US, an australian study also finds that at least 1 in 5 doctors who write influential clinical guidelines have had a financial relationship with a drug company that was not disclosed. Ray Moynihan of Bond University and Lisa Bero of University of Sydney speak up. DB Recovery note: The last time this was covered in the UK was here and here – time for similar research.